Trial Profile
Sequential treatment with nucleotide analogue and peg-interferon in patients with HBV-related chronic hepatitis.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2018
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms TRASANPIEC-HBV
- 21 Feb 2018 New trial record